IRIS Accounts Production v24.2.0.383 SC236596 director 1.1.23 31.12.23 31.12.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC2365962022-12-31SC2365962023-12-31SC2365962023-01-012023-12-31SC2365962021-12-31SC2365962022-01-012022-12-31SC2365962022-12-31SC236596ns15:Scotland2023-01-012023-12-31SC236596ns14:PoundSterling2023-01-012023-12-31SC236596ns10:Director12023-01-012023-12-31SC236596ns10:PrivateLimitedCompanyLtd2023-01-012023-12-31SC236596ns10:SmallEntities2023-01-012023-12-31SC236596ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-31SC236596ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-31SC236596ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-31SC236596ns10:FullAccounts2023-01-012023-12-31SC23659612023-01-012023-12-31SC236596ns10:RegisteredOffice2023-01-012023-12-31SC236596ns5:CurrentFinancialInstruments2023-12-31SC236596ns5:CurrentFinancialInstruments2022-12-31SC236596ns5:ShareCapital2023-12-31SC236596ns5:ShareCapital2022-12-31SC236596ns5:RetainedEarningsAccumulatedLosses2023-12-31SC236596ns5:RetainedEarningsAccumulatedLosses2022-12-31SC236596ns5:NetGoodwill2023-01-012023-12-31SC236596ns5:PlantMachinery2023-01-012023-12-31SC236596ns5:NetGoodwill2022-12-31SC236596ns5:NetGoodwill2023-12-31SC236596ns5:NetGoodwill2022-12-31SC236596ns5:PlantMachinery2022-12-31SC236596ns5:PlantMachinery2023-12-31SC236596ns5:PlantMachinery2022-12-31SC236596ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-31SC236596ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-31
REGISTERED NUMBER: SC236596 (Scotland)













FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

KELLOCK PHARMACY LIMITED

KELLOCK PHARMACY LIMITED (REGISTERED NUMBER: SC236596)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


KELLOCK PHARMACY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2023







DIRECTOR: D Kellock





REGISTERED OFFICE: 1 Coo Lane
Eaglesham
GLASGOW
G76 0JP





REGISTERED NUMBER: SC236596 (Scotland)





ACCOUNTANTS: Bannerman Johnstone Maclay
213 St Vincent Street
Glasgow
G2 5QY

KELLOCK PHARMACY LIMITED (REGISTERED NUMBER: SC236596)

BALANCE SHEET
31 DECEMBER 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 176,426 193,191
176,426 193,191

CURRENT ASSETS
Stocks 80,555 68,363
Debtors 6 234,379 92,942
Cash at bank and in hand 332,886 390,049
647,820 551,354
CREDITORS
Amounts falling due within one year 7 204,468 200,980
NET CURRENT ASSETS 443,352 350,374
TOTAL ASSETS LESS CURRENT
LIABILITIES

619,778

543,565

PROVISIONS FOR LIABILITIES 44,107 48,298
NET ASSETS 575,671 495,267

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 575,669 495,265
SHAREHOLDERS' FUNDS 575,671 495,267

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

KELLOCK PHARMACY LIMITED (REGISTERED NUMBER: SC236596)

BALANCE SHEET - continued
31 DECEMBER 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 12 September 2024 and were signed by:





D Kellock - Director


KELLOCK PHARMACY LIMITED (REGISTERED NUMBER: SC236596)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023


1. STATUTORY INFORMATION

Kellock Pharmacy Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2003, is being amortised evenly over its estimated useful life of twenty years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost and 10% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

KELLOCK PHARMACY LIMITED (REGISTERED NUMBER: SC236596)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023


2. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include certain debtors and cash and bank balances, are initially measured at transaction price including transactions costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including certain creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 8 (2022 - 8 ) .

KELLOCK PHARMACY LIMITED (REGISTERED NUMBER: SC236596)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023


4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 January 2023
and 31 December 2023 650,000
AMORTISATION
At 1 January 2023
and 31 December 2023 650,000
NET BOOK VALUE
At 31 December 2023 -
At 31 December 2022 -

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 January 2023 283,832
Additions 6,600
Disposals (1,580 )
At 31 December 2023 288,852
DEPRECIATION
At 1 January 2023 90,641
Charge for year 22,601
Eliminated on disposal (816 )
At 31 December 2023 112,426
NET BOOK VALUE
At 31 December 2023 176,426
At 31 December 2022 193,191

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 3,075 74,823
Amounts owed by related undertakings 211,575 81
Other debtors 19,729 18,038
234,379 92,942

KELLOCK PHARMACY LIMITED (REGISTERED NUMBER: SC236596)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023


7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 140,934 150,648
Taxation and social security 57,295 44,363
Other creditors 6,239 5,969
204,468 200,980

8. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Domkell Limited.